Export
Retatrutide
/wiki/retatrutide
The link always opens the latest version of this page.
Ask an AI about it
Open in ChatGPTA new chat that reads this entry from the site Open in ClaudeThe same, in Claude
Sending this to someone?
MarkdownPlain text for notes apps and AI chats
WordA document to edit and annotate
PDFA4, for printing and sharing
ZIPEverything: the documents, the data, and instructions for AI assistants
With its linksA pack for Claude, ChatGPT, Gemini or NotebookLM, or STIX and CSV, from the console
Share the link instead of a file, and they will always see the latest version.
Files are a snapshot of today. The live page has anything newer.
growing ·
3 feeds
Retatrutide
Snapshot
- Category
- triple-hormone receptor agonist 1 source
Intelligence coverage
Retatrutide is an injectable peptide developed by eli-lilly that functions as a glp-1-based therapeutic 12. It is administered via injection and represents a class of compounds targeting glucagon-like peptide-1 signaling pathways.
Facts 2
| Attribute | Value | Confidence | Sources | Cited |
|---|---|---|---|---|
| Vendor | Eli Lilly | medium | 2 | 1 |
| Category | triple-hormone receptor agonist | low | 1 | 2 |
Platform 2
GLP-1-based injectableinjectable peptide
Neighbourhood
Developed by 1
Supersedes 2
Official links
No official links recorded yet.
Work here? Claim this page with a verified company email or DNS record.